Erdem Gönüllü

Erdem Gönüllü

Auto-generated profile, based on publicly available information

Erdem Gönüllü

Division of Pediatric Pulmonology, Department of Pediatrics, Faculty of Medicine, Koç University, İstanbul, Türkiye

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2003 in Brain and Development
Verified
Journal Article
Closed access
AAAdem Aydin
Adem Aydin
KGKursad Genc̨
Kursad Genc̨
MAMustafa Akhisaroglu
Mustafa Akhisaroglu
KYKutsal Yorukoglu
Kutsal Yorukoglu
NGNecati Gokmen
Necati Gokmen
EGErdem Gonullu
Erdem Gonullu

19 June 2012 in Journal of Tropical Medicine
Verified
Journal Article
Open access
PDF file
ÖEÖzlem Erdoğan
Özlem Erdoğan
BTBilge Tanyeri
Bilge Tanyeri
ETEmel Torun
Emel Torun
EGErdem Gönüllü
Erdem Gönüllü
HAHüseyin Arslan
Hüseyin Arslan
FÖFaruk Öktem
Faruk Öktem
Objectives. The aim of the study is to compare the clinical effectiveness of the probiotics—Saccharomyces boulardiiandBifidobacterium lactis—in children who had been diagnosed with rotavirus gastroenteritis.Materials and methods. Seventy five patients aged between 5 months–5 years diagnosed as rotavirus gastroenteritis were included in the study. The patients diagnosed as rotavirus gastroenteritis by latex agglutination test in stool were divided into 3 groups of twenty-five patients each: First group was given oral rehydration therapy and rapid refeeding with a normal diet withSaccharomyces boulardii(spp. I-745), second group was given oral rehydration therapy and rapid refeeding with a normal diet withBifidobacterium lactis(spp. B94, culture number:) and third group received only oral rehydration therapy and rapid refeeding with a normal diet.Results. The duration of diarrhea was shorter in the group given oral rehydration therapy and rapid refeeding with a normal diet withBifidobacterium lactisandSaccharomyces boulardiithan the group given only oral rehydration therapy and rapid refeeding with a normal diet.Conclusion.Bifidobacterium lactishas a complemental role in the treatment of rotavirus gatroenteritis and other probiotics may also have a beneficial effect in rotavirus gastroenteritis compared with the therapy included only oral rehydration therapy and rapid refeeding with a normal diet.

27 March 2013 in International Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
ETEmel Torun
Emel Torun
EGErdem Gönüllü
Erdem Gönüllü
İÖİlker Tolga Özgen
İlker Tolga Özgen
ECErgül Cindemir
Ergül Cindemir
FÖFaruk Öktem
Faruk Öktem
Objectives. We aimed to determine the relationship between insulin resistance and serum 25-hydroxyvitamin D (25-OHD) levels in obese children and their nonobese peers.Materials and Methods. Included in the study group were 188 obese children (aged 9–15 years), and 68 age- and gender-matched healthy children of normal weight as control group. Anthropomorphic data were collected on patients and fasting serum glucose, insulin, serum lipids, alanine aminotransaminase (ALT) and 25-OHD were measured. The homeostatic model assessment of insulin resistance (HOMA-IR) was calculated in both groups.Results. The levels of 25-OHD in the obese group were significantly lower than those of the nonobese (). HOMA-IR, triglycerides, low-density lipoprotein, and ALT levels in the obese group were significantly higher than values of control group ( and , resp.). In the obese group, vitamin D deficiency, insufficiency, and sufficiency (25-OHD < 10 ng/dl, < 20, >10 ng/dl; > 20 ng/dl, resp.) were not correlated with HOMA-IR (, ). HOMA-IR was negatively correlated with BMI, BMI SDS, and BMI%, and triglycerides, low-density lipoprotein, and ALT levels ().Conclusion. The insulin resistance of the obese subjects who were vitamin D deficient and insufficient did not statistically differ from those with vitamin D sufficiency. Low 25-hydroxyvitamin D levels were not related with higher insulin resistance in obese children and adolescents. In obese subjects, insulin resistance was affected more from BMI, BMI SDS, and BMI% than from 25-hydroxyvitamin D levels.

16 April 2021 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Closed access
EGErdem Gönüllü
Erdem Gönüllü
ASAhmet Soysal
Ahmet Soysal
SASerkan Atıcı
Serkan Atıcı
MEMesut Engin
Mesut Engin
OYOsman Yeşilbaş
Osman Yeşilbaş
NKNalan Karabayır
Nalan Karabayır
Developing an effective and safe vaccine against Covid-19 will facilitate return to normal. Due to hesitation toward the vaccine, it is crucial to explore the acceptability of the COVID-19 vaccine to the public and healthcare workers. In this cross-sectional survey, we invited 2251 pediatricians and 506 (22%) of them responded survey and 424 (84%) gave either nasopharyngeal swap or antibody assay for COVID-19 and 71 (14%) of them got diagnosis of COVID-19. If the effective and safe COVID-19 vaccine was launched on market, 420 (83%) of pediatrician accepted to get vaccine shot, 422 (83%) of them recommended vaccination to their family members, 380 (75%) of them accepted to vaccine their children and 445 (85%) of them offered vaccination to their pediatric patients. Among the participated pediatricians 304 (60%) of them thought COVID-19 vaccine should be mandatory. We found that there are high COVID-19 vaccine willingness rates for pediatricians for themselves, their own children, family members and their pediatric patients. We also found that being a pediatric subspecialist, believing in achieving an effective vaccine, willingness to participate in the phase 1–2 clinical vaccine trial, willingness to get an influenza shot this season, believing a vaccine and vaccine passport should be mandatory were significant factors in accepting the vaccine. It is important to share all information about COVID-19 vaccines, especially effectiveness and safety, with the public in a clear communication and transparency. The opposite will contribute to vaccine hesitancy and anti-vaccine movement.

23 July 2020 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Closed access
ASAhmet Soysal
Ahmet Soysal
EGErdem Gönüllü
Erdem Gönüllü
IYİsmail Yıldız
İsmail Yıldız
MKMetin Karaböcüoğlu
Metin Karaböcüoğlu
The aim of the study was to investigate changes in the incidences of Varicella and Herpes Zoster (HZ) following introduction of single dose Varicella vaccine (VV) in Turkey. Changes in the incidences of varicella and HZ per 100,000 population were compared with pre (2011–2012) and post-VV period (2018–2019) throughout years between years 2011 and 2019 both for children and adults. In children ≤5 years of age, the annual incidences of varicella significantly decreased from 290 per 100000 children in 2011 to 24 per 100000 children in 2019 [p = .0001]. Also, for children ≤5 years the mean annual incidence of varicella decreased significantly [326/100000 ±51/100000 vs 23/100000 ± 1/100000; p = .014] between pre- and post-VV period. Moreover, the annual incidences of varicella significantly decreased from 43 per 100000 children in 2011 to 26 per 100000 children in 2019 in children age between 6 and 17 years. On the other hand, incidence of varicella in adult population (age >17 years) did not change significantly. Besides, the annual incidences of Herpes Zoster did not change significantly in children age stratas but significant increment observed in adult population. This increment was significant in adult age strata of 18–44 years, but non-significant in age strata of 45–64 years and >64 years. Thus, our study showed a significant reduction in the incidences of Varicella in children age stratas whereas significant increment in the incidence of HZ in adult population after the implementation of VV into the NIP of Turkey.

1 January 2012 in Journal of Pediatric Endocrinology and Metabolism
Verified
Journal Article
Closed access
TETorun Emel
Torun Emel
DDDemir Ayşegül Doğan
Demir Ayşegül Doğan
GEGönüllü Erdem
Gönüllü Erdem
ÖFÖktem Faruk
Öktem Faruk
Vitamin D deficiency can be treated with daily vitamin D supplementation for several weeks or single-day high-dose vitamin D therapy (stoss therapy). However, there are few studies comparing efficiency and side effects of these two treatment models. We aimed to compare the efficiency and side effects of low-dose stoss therapy and lower-dose daily vitamin D supplementation in children with vitamin D deficiency. Our subjects were 42 patients with ages between 5 months and 3 years with diagnosed vitamin D deficiency. All children had 25-hydroxyvitamin D level lower than 20 ng/mL. Serum biochemical markers and spot urine calcium/creatinine (Ca/Cr) ratio were measured before and after the therapy. Twenty-one patients were treated with stoss therapy (150,000 U/single-dose oral vitamin D3), and 21 patients were treated with daily high-dose vitamin D3 therapy (2000 U/day vitamin D, 6 weeks). Renal ultrasound was performed for both groups of patients after 1 month. Biochemical parameters and Ca/Cr ratio at the end of therapy did not differ in each groups. However, vitamin D levels at the end of stoss therapy were significantly increased compared with daily lower-dose vitamin D therapy group (p<0.001). Nephrocalcinosis or renal stone was not detected by renal ultrasound. In both groups, hypocalcemia was not detected during the therapy. There was no evidence about the increasing risk of hypercalciuria in low-stoss therapy. Higher vitamin D levels were obtained in low-stoss therapy group.